CTTH insider filings
CTT PHARMACEUTICAL HOLDINGS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-06. Screen CTTH transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 14 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 14 legs across 14 filings by 1 insider — 91,100 shares, $4,630 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 10,000 shares @ $0.06 ($590) by CTT PHARMACEUTICAL HOLDINGS, INC., filed 2026-08-19.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| CTT PHARMACEUTICAL HOLDINGS, INC. — CEO, Director | 14 | 14 legs · 91,100 sh · $4,630 | — | — |
Recent insider filings — CTT PHARMACEUTICAL HOLDINGS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-06 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO, Director | Purchase (P): 3,700 @ $0.06 | EDGAR |
| 2026-09-29 | 4/A | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO, Director | Purchase (P): 10,100 @ $0.04 | EDGAR |
| 2026-09-28 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO, Director | Purchase (P): 3,400 @ $0.06 | EDGAR |
| 2026-09-22 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO, Director | Purchase (P): 10,100 @ $0.04 | EDGAR |
| 2026-09-16 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO, Director | Purchase (P): 10,900 @ $0.05 | EDGAR |
| 2026-09-10 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 3,500 @ $0.05 | EDGAR |
| 2026-09-04 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 9,800 @ $0.05 | EDGAR |
| 2026-09-02 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 3,000 @ $0.05 | EDGAR |
| 2026-08-31 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 3,500 @ $0.05 | EDGAR |
| 2026-08-24 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 2,100 @ $0.06 | EDGAR |
| 2026-08-20 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 11,500 @ $0.04 | EDGAR |
| 2026-08-19 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 10,000 @ $0.06 | EDGAR |
| 2026-08-14 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,800 @ $0.06 | EDGAR |
| 2026-08-10 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 7,700 @ $0.07 | EDGAR |
| 2025-12-17 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 8,300 @ $0.06 | EDGAR |
| 2025-11-24 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — Director | Purchase (P): 200,000 @ $0.04 | EDGAR |
| 2025-11-21 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 62,900 @ $0.04 | EDGAR |
| 2025-10-31 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 7,000 @ $0.06 | EDGAR |
| 2025-10-07 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 6,815 @ $0.06 | EDGAR |
| 2025-09-23 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Grant/award (A): 750,000 @ $0.04 · Purchase (P): 44,085 @ $0.04 | EDGAR |
| 2025-08-01 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 15,800 @ $0.04 | EDGAR |
| 2025-07-08 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 8,000 @ $0.03 | EDGAR |
| 2025-06-30 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 39,600 @ $0.03 | EDGAR |
| 2025-06-23 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 16,100 @ $0.03 | EDGAR |
| 2025-06-13 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 54,798 @ $0.03 | EDGAR |
| 2025-06-09 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 82,158 @ $0.05 · Grant/award (A): 150,000 @ $0.06 | EDGAR |
| 2025-04-10 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 9,984 @ $0.07 | EDGAR |
| 2025-03-31 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 15,510 @ $0.05 | EDGAR |
| 2025-03-14 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 5,400 @ $0.06 | EDGAR |
| 2025-03-10 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 11,950 @ $0.09 | EDGAR |
| 2025-02-06 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 5,200 @ $0.12 | EDGAR |
| 2024-11-26 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 23,346 @ $0.06 | EDGAR |
| 2024-09-13 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 750 @ $0.06 · Grant/award (A): 750,000 @ $0.04 | EDGAR |
| 2024-09-11 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,100 @ $0.06 | EDGAR |
| 2024-09-03 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,000 @ $0.06 | EDGAR |
| 2024-08-27 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 550 @ $0.06 | EDGAR |
| 2024-08-21 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 2,900 @ $0.05 | EDGAR |
| 2024-08-15 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,300 @ $0.04 | EDGAR |
| 2024-08-09 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 2,200 @ $0.04 | EDGAR |
| 2024-08-06 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,000 @ $0.04 | EDGAR |
| 2024-08-02 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,600 @ $0.04 | EDGAR |
| 2024-07-30 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 3,100 @ $0.04 | EDGAR |
| 2024-07-26 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,700 @ $0.04 | EDGAR |
| 2024-07-24 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 2,000 @ $0.05 | EDGAR |
| 2024-07-18 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,800 @ $0.06 | EDGAR |
| 2024-07-15 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,070 @ $0.06 | EDGAR |
| 2024-07-11 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 2,730 @ $0.06 | EDGAR |
| 2024-07-05 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,454 @ $0.06 | EDGAR |
| 2024-06-28 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,300 @ $0.06 | EDGAR |
| 2024-06-24 | 4 | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Purchase (P): 1,000 @ $0.07 | EDGAR |
Recent 8-K events — CTT PHARMACEUTICAL HOLDINGS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-07 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CTTH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →